Company No: 08605096 (England and Wales)

Contents

• Statement of Financial Position
• Notes to the Financial Statements

	Note	2024		2023
		£		£
Fixed assets
Investments	3	10,081,835		9,633,202
		10,081,835		9,633,202
Net current assets		0		0
Total assets less current liabilities		10,081,835		9,633,202
Net assets		10,081,835		9,633,202
Capital and reserves
Called-up share capital	4	16,282		12,754
Share premium account		12,077,000		9,963,752
Other reserves		356,496		251,550
Profit and loss account		( 2,367,943 )		( 594,854 )
Total shareholder's funds		10,081,835		9,633,202

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Living Map Assets Limited (registered number: 08605096) were approved and authorised for issue by the Board of Directors on 30 September 2025. They were signed on its behalf by:

A E P Coxen Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Living Map Assets Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Bishop Fleming Llp, 10 Temple Back, Bristol, BS1 6FL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors note that the subsidiary company has net assets of £509,620. The subsidiary company is supported by the Company and investments from third parties into the Company. The directors have confirmed that as at the date of signing the accounts the company has received a further £400,000 investment committed from existing shareholders and the company will be able to continue for at least 12 months from the date of signing these financial statements. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Share-based payment

Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions.

Fair value is measured by use of the appropriate pricing model which is considered by management to be the most appropriate method of valuation. The expected life used in the model has been adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations.

Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Investments
Investments in non-convertible preference shares and non-puttable ordinary or preference shares (where shares are publicly traded or their fair value is reliably measurable) are measured at fair value through the Statement of Income and Retained Earnings. Where fair value cannot be measured reliably, investments are measured at cost less impairment.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

	2024		2023
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	4		4

3. Fixed asset investments

Investments in subsidiaries

	2024
	£
Cost
At 01 January 2024	9,633,202
Additions	2,221,722
At 31 December 2024	11,854,924
Provisions for impairment
At 01 January 2024	0
Impairment	1,773,089
At 31 December 2024	1,773,089
Carrying value at 31 December 2024	10,081,835
Carrying value at 31 December 2023	9,633,202

4. Called-up share capital

	2024		2023
	£		£
Allotted, called-up and fully-paid
16,281,876 Ordinary shares of £ 0.001 each (2023: 12,753,916 shares of £ 0.001 each)	16,282		12,754

During the year 3,527,960 (2023 - 2,305,085) ordinary shares were allotted at £0.60 per share.

Other reserves include all current and previous share based payment charges recognised in share option schemes net of any related deferred tax assets and transfers upon exercise of options.

5. Contingencies

As part of his consultancy agreement Adam Coxen is entitled to receive a payment that is contingent on a change of control of the business occurring. This payment is to be calculated using the ordinary share price at the time of the change of control multiplied by 148,292.